位置:成果数据库 > 期刊 > 期刊详情页
靶向人多药耐药基因mrp1特异性小分子干扰RNA有效序列筛选
  • ISSN号:1672-4992
  • 期刊名称:《现代肿瘤医学》
  • 时间:0
  • 分类:R730[医药卫生—肿瘤;医药卫生—临床医学] R735.7[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]西安市第四医院普外科,陕西西安710004, [2]成都地奥制药有限公司基因工程研究室,四川成都610041, [3]四川大学华西医院普外科,四川成都610041
  • 相关基金:国家自然科学基金资助项目(编号:30170925)
中文摘要:

目的:筛选靶向人多药耐药相关蛋白基因(mrp1)特异性小分子干扰RNA(siRNA)的有效序列。方法:设计并体外转录合成靶向mrp1的4条siRNA(mrp1-si251,mrp1-si480,mrp1-si795,mrp1-si1016和空白对照si-阴性),转染转基因单因素肝癌多药耐药细胞Hep G2/mrp1。用RT-PCR检测mrp1 mRNA表达,流式细胞仪检测多药耐药相关蛋白表达、细胞内柔红霉素(DNR)蓄积,四甲基偶氮唑蓝(MTT)法检测细胞对阿霉素(ADM)的敏感性。结果:4条siRNA均能不同程度逆转Hep G2/mrp1细胞由mrp1介导的多药耐药。转染72h后,mrp1-si795组和mrp1-si1016组的mrp1 mRNA表达水平分别分别下调了(86.36±2.26)%和(85.54±1.04)%,较mrp1-si251组和mrp1-si480组明显下降(P〈0.05);细胞内柔红霉素蓄积由多到少依次为mrp1-si795组最多,mrp1-si1016组次之,mrp1-si480组较少,mrp1-si251组最少(P〈0.05);mrp1-si795组对ADR耐药的相对逆转率(86.36%)最高,mrp1-si1016组(85.54%)次之,较mrp1-si251组(60.93%)和mrp1-si480组(70.29%)有明显差异(P〈0.05);mrp1-si1016组和mrp1-si795组多药耐药相关蛋白表达明显下调。结论:实验设计的靶向mrp1 mRNA的siRNA序列能够不同程度逆转多药耐药相关蛋白介导的人肝癌耐药细胞HepG 2/mrp1的多药耐药性,mrp1-si1016和mrp1-si795效果最好,mrp1-si480较差,mrp1-si251最差。mrp1-si1016和mrp1-si795可以作为进一步实验的靶序列。

英文摘要:

Objective: To screen effective sequences of small interfering RNA targeting human multidrug associated- protein gene( mrp1). Methods: Four siRNAs( mrp1- si251,mrp1- si480,mrp1- si795,mrp1- si1016) targeting mrp1 genes were designed and synthesized by in vitro transcription. The siRNA duplexes were used to transfected into the human hepatocellular carcinoma HepG2 / mrp1 cells,which transfected with human mrp1 gene and obtained MDR phenomenon. The expression level of mrp1 mRNA was detected by RT- PCR. The multidru resistance- associated protein and accumulation of intracellular daunorubicin( DNR) were examined by flow cytometry,respectively. The cell sensitivity to adriamycin( ADM) was demonstrated by MTT. Results: The HepG2 / mrp1 cells treated with 4 siRNAs led to reversal effectively on multidrug resistance to different extents. Among the HepG2 / mrp1 cells treated by siRNAs for 7 2 h,the expression level of mrp1 mRNA in cells of mrp1- si1016 or mrp1- si795 groups[( 85. 54± 1. 04) % or( 86. 36 ± 2. 26) %]was more decreased than that in cells of mrp1- si2 5 1 or mrp1- si4 8 0groups( P〈0. 05). The accumulation of DNR in cells of mrp1- si795 group was the most. In cells of mrp1- si1016 group,more,in cells of mrp1- si480 group,lower,and in cells of mrp1- si251 group,the lowest( P〈0. 05). The relative reversal efficiency of cells of mrp1- si1016 and mrp1- si795 groups to ADR was higher than in the cells of mrp1- si251 and mrp1- si480 groups significantly( P〈0. 05). The expression level of multidrug resistance- associated protein in cells of mrp1- si1016 and mrp1- si795 groups was lowest among the HepG2 / mrp1 cells treated by siRNAs for 72 h. Conclusion: The mrp1- si795 with most,mrp1- si1016 with more,mrp1- si480 with less and mrp1- si251 with least reversal effects on mrp1 gene mediated multidrug resistance were found in the human hepatocellular carcinoma HepG2 / mrp1 cells.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《现代肿瘤医学》
  • 中国科技核心期刊
  • 主管单位:陕西省科学技术协会
  • 主办单位:中国抗癌协会 陕西省抗癌协会 陕西省肿瘤防治研究所 (西安交通大学附属陕西省肿瘤医院)
  • 主编:李树业
  • 地址:西安市雁塔西路309号陕西省肿瘤医院内
  • 邮编:710061
  • 邮箱:sxzlyx@263.net
  • 电话:029-85277356
  • 国际标准刊号:ISSN:1672-4992
  • 国内统一刊号:ISSN:61-1415/R
  • 邮发代号:52-297
  • 获奖情况:
  • 获《CAJ-CD规范》执行优秀期刊奖,陕西省优秀科技期刊一等奖,中国抗癌协会优秀期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),中国中国科技核心期刊
  • 被引量:30005